Supporting evidence
Insulin degludec × HbA1c
- Authoritative support
- 3
- Available studies
- 3
- Unavailable support
- 0
Available supporting studies
Study 1 · Included
Efsitora improves HbA1c control compared to degludec in Japanese adults.
Rct
- Comparison
- Participants received once weekly insulin efsitora. · Participants received once daily insulin degludec.
- Duration / follow-up
- 52 weeks
Relevant effects
Mean difference
1.41
Mean difference
1.36
Study 2 · Included
IDegAsp improves HbA1c compared to IGlar in type 2 diabetes
Rct
- Comparison
- Participants received insulin degludec/insulin aspart for 20 weeks. · Participants received insulin glargine for 20 weeks.
- Duration / follow-up
- 20 weeks
Relevant effects
Mean difference
0.21 · 0.031
Mean difference
0.21 · 0.031
Study 3 · Included
IDegAsp may reduce nocturnal hypoglycemia compared to IGlar in T2DM patients
Rct
- Comparison
- Participants received IDegAsp once daily with breakfast. · Participants received IGlar once daily as per label.
- Duration / follow-up
- 52 weeks
Relevant effects
Mean difference
0.08
Mean difference
0.08